Simulations Plus to Participate in Upcoming Healthcare Conferences Feb 6, 2024 08:30AM
Simulations Plus Releases GastroPlus® Version 9.9 Jan 30, 2024 08:30AM
Simulations Plus Embarks on Collaboration with Northeastern University and The TIM Company Through New FDA Grant Jan 9, 2024 08:30AM
Simulations Plus Reports First Quarter Fiscal 2024 Financial Results Jan 3, 2024 04:06PM
Simulations Plus Announces Leadership Appointments Supporting Commitment to Clients and Driving Growth Jan 3, 2024 04:05PM
View Older Stories

Dec 20, 2023 08:30AM Simulations Plus Announces First Quarter Fiscal Year 2024 Earnings and Conference Call Date
Nov 14, 2023 08:00AM Simulations Plus Outlines Paths to Win at 2023 Investor Day
Nov 8, 2023 08:30AM ISoP New Board of Trustees Members Announced
Oct 31, 2023 08:30AM Simulations Plus to Host Investor Day on Tuesday, November 14th
Oct 25, 2023 04:06PM Simulations Plus Reports Fourth Quarter and Fiscal 2023 Financial Results
Oct 11, 2023 04:06PM Simulations Plus Announces Fourth Quarter and Fiscal Year 2023 Earnings Release and Conference Call
Sep 21, 2023 08:30AM Simulations Plus (SLP) Receives New FDA Grant Award
Sep 21, 2023 08:30AM Simulations Plus Receives New FDA Grant Award
Sep 7, 2023 08:30AM Simulations Plus Hosts First-of-its-Kind Virtual Summer Camp for Students and Professors
Aug 24, 2023 08:30AM Simulations Plus Chief Science Officer Dr. Viera Lukacova Honored as Fellow by the American Association of Pharmaceutical Scientists (AAPS)
Aug 15, 2023 08:30AM Researchers Use the Simulations Plus DILIsym® Platform to Predict Safety of Combined CBD and VPA Treatment
Jul 13, 2023 08:30AM Simulations Plus Releases ADMET Predictor® 11
Jul 6, 2023 04:06PM Simulations Plus Reports Third Quarter Fiscal 2023 Financial Results
Jun 21, 2023 04:06PM Simulations Plus Announces Third Quarter Fiscal Year 2023 Earnings and Conference Call Date
Jun 20, 2023 08:00AM Simulations Plus (SLP) Acquires Immunetrics
Jun 20, 2023 08:00AM Simulations Plus Acquires Immunetrics to Expand its Immunology and Oncology Drug Development Capabilities
May 10, 2023 08:30AM Simulations Plus Launches New Integrated Pulmonary Software and Services Package to Streamline Drug Development and Improve Patient Outcomes
Apr 18, 2023 08:31AM Simulations Plus (SLP) Receives FDA Renewal for DILIsym Software Licenses
Apr 18, 2023 08:30AM Simulations Plus Receives U.S. FDA Renewal for DILIsym Software Licenses
Apr 5, 2023 04:06PM Simulations Plus Reports Second Quarter Fiscal 2023 Financial Results
Mar 30, 2023 08:30AM MIDD+ 2023 Panelists Discuss How to Increase Gender Equity for Women in Science
Mar 28, 2023 08:33AM Simulations Plus (SLP) Enters New Strategic Collaboration to Discover Anticancer Therapies Through Its AI-Driven Drug Design Technology
Mar 28, 2023 08:30AM Simulations Plus Enters New Strategic Collaboration to Discover Anticancer Therapies Through Its AI-Driven Drug Design Technology
Mar 21, 2023 04:06PM Simulations Plus Sets Date for Second Quarter Fiscal Year 2023 Earnings Release and Conference Call
Mar 16, 2023 08:30AM Simulations Plus to Present at Sidoti March Small-Cap Conference
Mar 15, 2023 08:30AM Simulations Plus Enters Partnership to Apply AI/ML Technologies to Design Novel Compounds
Mar 9, 2023 08:30AM Lixoft Adds New Data Formatting and Reporting Modules to MonolixSuite™ in Version 2023R1
Mar 7, 2023 08:30AM Simulations Plus to Present at Oppenheimer 33rd Annual Healthcare Conference
Feb 28, 2023 08:30AM Simulations Plus to Present at Raymond James 44th Annual Institutional Investors Conference
Feb 16, 2023 08:37AM Simulations Plus (SLP) and Global Agrochemicals Leader to Collaborate on Machine Learning Models
Feb 16, 2023 08:30AM Simulations Plus and Global Agrochemicals Leader to Collaborate on Machine Learning Models
Feb 9, 2023 08:30AM Simulations Plus Releases Redesigned NAFLDsym® QSP Software Tool
Jan 12, 2023 08:30AM Simulations Plus Releases DILIsym X (DSX) Beta with Redesigned Software Infrastructure
Jan 12, 2023 04:59AM Simulations Plus (SLP) Executes $20M Accelerated Share Buyback
Jan 11, 2023 06:14PM Simulations Plus Executes $20 Million Accelerated Share Repurchase Agreement
Jan 4, 2023 04:06PM Simulations Plus Reports First Quarter Fiscal 2023 Financial Results
Dec 19, 2022 04:06PM Simulations Plus Sets Date for First Quarter Fiscal Year 2023 Earnings Release and Conference Call
Nov 15, 2022 08:34AM Simulations Plus (SLP) and the University of Bath Awarded New FDA Grant
Nov 15, 2022 08:30AM Simulations Plus and the University of Bath Awarded New FDA Grant
Nov 10, 2022 08:30AM Gustavo Mendes Lima Santos Joins the Simulations Plus Regulatory Fellowship Program
Nov 3, 2022 08:30AM Simulations Plus 25th Anniversary Celebration Concludes with $25,000 Gift to Nonprofit, Girls Who Code
Nov 2, 2022 08:32AM Simulations Plus (SLP), University of Florida Awarded New FDA Contract to Support Development and Regulatory Assessment of Inhaled Products
Nov 2, 2022 08:30AM Simulations Plus and the University of Florida Awarded New FDA Contract to Support Development and Regulatory Assessment of Inhaled Products
Oct 26, 2022 04:06PM Simulations Plus Reports Fourth Quarter and Full Fiscal Year 2022 Financial Results
Oct 20, 2022 04:15PM Simulations Plus Announces Cash Dividend
Oct 12, 2022 08:30AM Simulations Plus Releases GastroPlus® Version 9.8.3
Oct 11, 2022 04:06PM Simulations Plus Sets Date for Fourth Quarter and Fiscal Year 2022 Earnings Release and Conference Call
Sep 14, 2022 08:30AM Simulations Plus to Present at Sidoti Fall Small Cap Investor Conference
Sep 7, 2022 08:30AM Simulations Plus to Present at Baird 2022 Global Healthcare Conference
Aug 31, 2022 08:30AM Simulations Plus Releases State-of-the-Art QSP Software for Interstitial Lung Disease
View Older Stories